Target
MAP kinase-interacting serine/threonine-protein kinase 2
Ligand
BDBM136243
Substrate
n/a
Meas. Tech.
Inhibition Assay
pH
7.4±n/a
Temperature
303.15±n/a K
IC50
24±n/a nM
Comments
extracted
Citation
 Heckel, AHimmelsbach, FKley, JLehmann-Lintz, TRedemann, NSauer, AThomas, LWiedenmayer, DBlack, PBlackaby, WLinney, IAusten, MDanilewicz, JSchneider, MSchreiter, K Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositions US Patent  US8853193 Publication Date 10/7/2014 
Target
Name:
MAP kinase-interacting serine/threonine-protein kinase 2
Synonyms:
GPRK7 | MAP kinase signal-integrating kinase 2 | MAP kinase-interacting serine/threonine-protein kinase 2 (MKNK2) | MAP kinase-interacting serine/threonine-protein kinase 2 (MnK2) | MAP-kinase interacting kinase 2 (MNK2) | MKNK2 | MKNK2_HUMAN | MNK2
Type:
Protein
Mol. Mass.:
51870.79
Organism:
Homo sapiens (Human)
Description:
Q9HBH9
Residue:
465
Sequence:
MVQKKPAELQGFHRSFKGQNPFELAFSLDQPDHGDSDFGLQCSARPDMPASQPIDIPDAKKRGKKKKRGRATDSFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMVLQRNSCAKDLTSFAAEAIAMNRQLAQHDEDLAEEEAAGQGQPVLVRATSRCLQLSPPSQSKLAQRRQRASLSSAPVVLVGDHA
  
Inhibitor
Name:
BDBM136243
Synonyms:
US8853193, 36-15
Type:
Small organic molecule
Emp. Form.:
C21H23N7O2S
Mol. Mass.:
437.518
SMILES:
CC(C)Oc1ncccc1Nc1ncnc2sc(C(=O)NCc3cn(C)cn3)c(C)c12
Structure:
Search PDB for entries with ligand similarity: